alpha-blockers

DRUG2 trials

Sponsors

GlaxoSmithKline, Moscow State University of Medicine and Dentistry

Conditions

Benign Prostatic HyperplasiaProstatic Hyperplasia

Unknown Phase

WEUSKOP5723: Prostate Cancer Study

CompletedNCT01767363

GlaxoSmithKlineProstatic Hyperplasia

Start: 2012-11-30End: 2016-03-31Updated: 2016-11-09

Intermittent Catheterization Versus Trial Without Catheter

Moscow State University of Medicine and DentistryBenign Prostatic Hyperplasia

Start: 2021-08-03End: 2022-05-31Target: 200Updated: 2021-10-26